Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-22

FDA Approved: DIHYDROERGOTAMINE MESYLATE — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approved an original application for dihydroergotamine mesylate from Advagen Pharma Ltd, establishing this product as a new approved option. The drug is ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dihydroergotamine mesylate (Dihydroergotamine Mesylate)

Snippet

ORIG AP for DIHYDROERGOTAMINE MESYLATE (DIHYDROERGOTAMINE MESYLATE)